For loricrin, reduced mRNA expression in the tumor margin of SCC was observed compared to normal skin (0.073±0.021, p<0.001), the tumor center (8.29±5.29, p<0.001) and peritumoral tissue (0.33±0.08, p<0.05) (Figure 2). This evidence concerns the gene LORICRIN and neoplasm.